Advertisement

Topics

Alkermes plc Company Profile

00:38 EST 24th November 2017 | BioPortfolio

Alkermes plc is a fully integrated, global biopharmaceutical company that applies its scientific expertise and proprietary technologies to develop innovative medicines that improve patient outcomes. The company has a diversified portfolio of more than 20 commercial drug products and a substantial clinical pipeline of product candidates that address central nervous system (CNS) disorders such as addiction, schizophrenia and depression. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts and manufacturing facilities in Athlone, Ireland; Gainesville, Georgia; and Wilmington, Ohio.

Location

Treasury Building
Lower Grand Canal Street
Dublin
2
Ireland

Contact

Phone: +353 1 772 8000
Email: financial@alkermes.com


News Articles [66 Associated News Articles listed on BioPortfolio]

Contrasting Alkermes PLC

Alkermes PLC and Nabriva Therapeutics AG are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, profitability, divide...

Blair Jackson of Alkermes discusses their merger with Elan Drug Technologies to create Alkermes plc

In this episode of PharmaTelevision News Review, Fintan Walton talks to Blair Jackson, Vice President of Business Development at Alkermes

Alkermes Says FDA Accepts NDA Filing On ARISTADA

WASHINGTON (dpa-AFX) - Alkermes plc (ALKS) said that the New Drug Application for Aripiprazole Lauroxil NanoCrystal Dispersion or ALNCD, a novel, investigational product designed for initiation on...

Alkermes’ Corporate Presentation to be Webcast at the Jefferies 2017 London Healthcare Conference

Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Jefferies 2017 London Healthcare Conference on Wednesday, Nov. 15, 2...

Alkermes’ Corporate Presentation to be Webcast at the Credit Suisse 26th Annual Healthcare Conference

Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Credit Suisse 26th Annual Healthcare Conference on Tuesday, Nov. 7, ...

Alkermes to Present at the Morgan Stanley 15th Annual Global Healthcare Conference

Alkermes plc (NASDAQ: ALKS) announced today that its Chief Financial Officer, James Frates, will participate in a fireside chat at the Morgan Stanley 15th Annual Global Hea...

Alkermes Reveals Recipients of the 2nd Annual Competitive Grants Program to Support Those ...

— ALKERMES INSPIRATION GRANTS® Program Awards $1 Million to Non-Profit Organizations for the Development or Expansion of Innovative Programs — Read more...

Alkermes Initiates NDA Submission Of ALKS 5461 For Major Depressive Disorder

WASHINGTON (dpa-AFX) - Alkermes plc (ALKS), a biopharmaceutical company focused on the central nervous system or CNS, diseases, announced Monday the initiation of its rolling submission of a New D...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [9 Associated Clinical Trials listed on BioPortfolio]

Long-Term Safety Study of Naltrexone Long Acting Injection in Alcohol Dependent Adults

This is a multi-center extension of Alkermes study ALK21-003EXT to further assess the long-term safety of repeat monthly doses of naltrexone long acting injection.

Long-Term Safety Study of Naltrexone Long Acting Injection in Alcohol or Opiate Dependent Adults.

This is a multi-center extension of Alkermes study ALK21-006 to further assess the long-term safety of repeat monthly doses of naltrexone long acting injection.

Study of Human Insulin Inhalation Powder in Patients With Type 2 Diabetes

This is a phase 3, open-label, randomized study to evaluate the safety and efficacy of the Lilly/Alkermes inhaled insulin system compared to injected pre-meal insulin in non-smoking patien...

Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes

This is a phase 3, open-label, randomized study to evaluate the safety and efficacy of the Lilly/Alkermes inhaled insulin system compared to injected pre-meal insulin in non-smoking patien...

Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes

A study to compare Human Inhalation Powder (also known as AIR® Inhaled Insulin) (AIR® is a registered trademark of Alkermes, Inc.)with insulin glargine injections in patients with Type 2...

Companies [5 Associated Companies listed on BioPortfolio]

Alkermes plc

Alkermes plc is a fully integrated, global biopharmaceutical company that applies its scientific expertise and proprietary technologies to develop innovative medicines that improve patient outcomes....

Alkermes, Inc. and Amylin Pharmaceuticals, Inc. and Eli Lilly and Company

Alkermes, Inc. & Amylin Pharmaceuticals, Inc. & Eli Lilly and Company

Acceleron Pharma, Inc.

Acceleron is a privately held biopharmaceutical company committed to discover, develop, manufacture and commercialize novel biotherapeutics that modulate the growth of red blood c...

Addison Whitney

Addison Whitney is a strategic branding consultancy that specializes in the pharmaceutical industry. With over ten years' experience in pharmaceutical branding, our strategic offerings include: * ...

More Information about "Alkermes plc" on BioPortfolio

We have published hundreds of Alkermes plc news stories on BioPortfolio along with dozens of Alkermes plc Clinical Trials and PubMed Articles about Alkermes plc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alkermes plc Companies in our database. You can also find out about relevant Alkermes plc Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record